Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Iproteos

Iproteos
2011 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
5 INVESTORS
Description

Operator of a biotechnology company designed to develop next-generation drugs to treat cardiovascular and central nervous systems. The company's biotechnology center specializes in the research and development of third-generation drugs, such as protein-protein interactions (PPIs), enabling medical professionals to treat schizophrenia, epilepsy, pediatric cancer and other neurological disorders.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Baldiri Reixac, 10
  • Barcelona Science Park
  • 08028 Barcelona
  • Spain

+34 934 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Iproteos’s full profile, request a free trial.

Iproteos Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 29-May-2017 00.000 Completed Generating Revenue
5. Early Stage VC (Series A) 25-Oct-2016 00.000 00.000 Completed Pre-Clinical Trials
4. Angel (individual) 26-Sep-2016 00000 00000 Completed Pre-Clinical Trials
3. Angel (individual) 01-Nov-2014 00000 00000 Completed Startup
2. Grant 01-Jan-2014 $686K $144K Completed Startup
1. Capitalization 01-Jan-2012 $144K $144K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Iproteos Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Avidity Biosciences Venture Capital-Backed La Jolla, CA 00000 000000000000 00000
00000000 000000000 Pending Transaction (M&A) New York, NY 000000&0
000000 00000000000 Venture Capital-Backed San Diego, CA 000.00 00000000000 000.00
0000000 0000000000 Venture Capital-Backed Barcelona, Spain 00 000.00 00000000000 000.00
0000000 0000000000 Formerly VC-backed Richmond, CA 000 000.00 00000000 000.00
To view this company’s complete list of competitors, request access »

Iproteos Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
ASCIL Biopharm Other Minority 000 0000 000000 0
Caixa Capital Risc Corporate Venture Capital Minority 000 0000 000000 0
Kinled Holding Venture Capital Minority 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
Ministerio de Economía, Industria y Competitividad Government 000 0000 000000 0

Iproteos Executive Team (5)

Name Title Board
Seat
Contact
Info
Teresa Tarragó Ph.D Co-Founder & Chief Executive Officer
Laura Mendieta Ph.D Chief Operating Officer
Roger Prades Ph.D Chief Scientific Officer
Ernest Giralt Ph.D Co-Founder, Chairman & Member of Advisory Board
Xavier Sansó Chief Financial Officer

Iproteos Board Members (1)

Name Representing Role Since Contact
Info
Ernest Giralt Ph.D Iproteos Co-Founder, Chairman & Member of Advisory Board 000 0000